Connecting genomic and proteomic signatures of amyloid burden in the brain
Raquel Puerta, Itziar de Rojas, Pablo García-González, Clàudia Olivé, Oscar Sotolongo-Grau, Ainhoa García-Sánchez, Fernando García-Gutiérrez, Laura Montrreal, Juan Pablo Tartari, Ángela Sanabria, Vanesa Pytel, Carmen Lage, Inés Quintela, Nuria Aguilera, Eloy Rodriguez-Rodriguez, Emilio Alarcón-Martín, Adelina Orellana, Pau Pastor, Jordi Pérez-Tur, Gerard Piñol-Ripoll, Adolfo López de Munian, Jose María García-Alberca, Jose Luís Royo, María Jesús Bullido, Victoria Álvarez, Luis Miguel Real, Arturo Corbatón Anchuelo, Dulcenombre Gómez-Garre, María Teresa Martínez Larrad, Emilio Franco-Macías, Pablo Mir, Miguel Medina, Raquel Sánchez-Valle, Oriol Dols- Icardo, María Eugenia Sáez, Ángel Carracedo, Lluís Tárraga, Montse Alegret, Sergi Valero, Marta Marquié, Mercè Boada, Pascual Sánchez Juan, Jose Enrique Cavazos, Alfredo Cabrera, Amanda Cano, Agustín Ruiz, Alzheimer’s Disease Neuroimaging Initiative
doi: https://doi.org/10.1101/2024.09.06.24313124
Raquel Puerta
1Ace Alzheimer Center Barcelona – Universitat Internacional de Catalunya, Spain
2Universitat de Barcelona (UB)
Itziar de Rojas
1Ace Alzheimer Center Barcelona – Universitat Internacional de Catalunya, Spain
3CIBERNED, Network Center for Biomedical Research in Neurodegenerative Diseases, National Institute of Health Carlos III, Madrid, Spain
Pablo García-González
1Ace Alzheimer Center Barcelona – Universitat Internacional de Catalunya, Spain
3CIBERNED, Network Center for Biomedical Research in Neurodegenerative Diseases, National Institute of Health Carlos III, Madrid, Spain
Clàudia Olivé
1Ace Alzheimer Center Barcelona – Universitat Internacional de Catalunya, Spain
Oscar Sotolongo-Grau
1Ace Alzheimer Center Barcelona – Universitat Internacional de Catalunya, Spain
Ainhoa García-Sánchez
1Ace Alzheimer Center Barcelona – Universitat Internacional de Catalunya, Spain
Fernando García-Gutiérrez
1Ace Alzheimer Center Barcelona – Universitat Internacional de Catalunya, Spain
Laura Montrreal
1Ace Alzheimer Center Barcelona – Universitat Internacional de Catalunya, Spain
Juan Pablo Tartari
1Ace Alzheimer Center Barcelona – Universitat Internacional de Catalunya, Spain
Ángela Sanabria
1Ace Alzheimer Center Barcelona – Universitat Internacional de Catalunya, Spain
3CIBERNED, Network Center for Biomedical Research in Neurodegenerative Diseases, National Institute of Health Carlos III, Madrid, Spain
Vanesa Pytel
1Ace Alzheimer Center Barcelona – Universitat Internacional de Catalunya, Spain
3CIBERNED, Network Center for Biomedical Research in Neurodegenerative Diseases, National Institute of Health Carlos III, Madrid, Spain
Carmen Lage
4Neurology Service, Marqués de Valdecilla University Hospital (University of Cantabria and IDIVAL), Santander, Spain
3CIBERNED, Network Center for Biomedical Research in Neurodegenerative Diseases, National Institute of Health Carlos III, Madrid, Spain
Inés Quintela
5Grupo de Medicina Xenómica, Centro Nacional de Genotipado (CEGEN-PRB3-ISCIII). Universidade de Santiago de Compostela, Santiago de Compostela, Spain
Nuria Aguilera
1Ace Alzheimer Center Barcelona – Universitat Internacional de Catalunya, Spain
Eloy Rodriguez-Rodriguez
4Neurology Service, Marqués de Valdecilla University Hospital (University of Cantabria and IDIVAL), Santander, Spain
3CIBERNED, Network Center for Biomedical Research in Neurodegenerative Diseases, National Institute of Health Carlos III, Madrid, Spain
Emilio Alarcón-Martín
1Ace Alzheimer Center Barcelona – Universitat Internacional de Catalunya, Spain
Adelina Orellana
1Ace Alzheimer Center Barcelona – Universitat Internacional de Catalunya, Spain
3CIBERNED, Network Center for Biomedical Research in Neurodegenerative Diseases, National Institute of Health Carlos III, Madrid, Spain
Pau Pastor
6Unit of Neurodegenerative diseases, Department of Neurology, University Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain
7The Germans Trias i Pujol Research Institute (IGTP), Badalona, Barcelona, Spain
Jordi Pérez-Tur
8Unitat de Genètica Molecular, Institut de Biomedicina de València-CSIC, Valencia, Spain
3CIBERNED, Network Center for Biomedical Research in Neurodegenerative Diseases, National Institute of Health Carlos III, Madrid, Spain
9Unidad Mixta de Neurologia Genètica, Instituto de Investigación Sanitaria La Fe, Valencia, Spain
Gerard Piñol-Ripoll
10Unitat Trastorns Cognitius, Hospital Universitari Santa Maria de Lleida, Lleida, Spain
11Institut de Recerca Biomedica de Lleida (IRBLLeida), Lleida, Spain
Adolfo López de Munian
12Department of Neurology. Hospital Universitario Donostia. San Sebastian, Spain
13Department of Neurosciences. Faculty of Medicine and Nursery. University of the Basque Country, San Sebastián, Spain
3CIBERNED, Network Center for Biomedical Research in Neurodegenerative Diseases, National Institute of Health Carlos III, Madrid, Spain
14Neurosciences Area. Instituto Biodonostia. San Sebastian, Spain
Jose María García-Alberca
15Alzheimer Research Center & Memory Clinic, Andalusian Institute for Neuroscience, Málaga, Spain
3CIBERNED, Network Center for Biomedical Research in Neurodegenerative Diseases, National Institute of Health Carlos III, Madrid, Spain
Jose Luís Royo
16Departamento de Especialidades Quirúrgicas, Bioquímica e Inmunología. School of Medicine. University of Malaga. Málaga, Spain
María Jesús Bullido
17Centro de Biología Molecular Severo Ochoa (UAM-CSIC)
3CIBERNED, Network Center for Biomedical Research in Neurodegenerative Diseases, National Institute of Health Carlos III, Madrid, Spain
18Instituto de Investigacion Sanitaria ‘Hospital la Paz’ (IdIPaz), Madrid, Spain
19Universidad Autónoma de Madrid.
Victoria Álvarez
20Laboratorio de Genética. Hospital Universitario Central de Asturias, Oviedo, Spain
21Instituto de Investigación Sanitaria del Principado de Asturias (ISPA).
Luis Miguel Real
22Unidad Clínica de Enfermedades Infecciosas y Microbiología.Hospital Universitario de Valme, Sevilla, Spain
16Departamento de Especialidades Quirúrgicas, Bioquímica e Inmunología. School of Medicine. University of Malaga. Málaga, Spain
Arturo Corbatón Anchuelo
23Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Hospital Clínico San Carlos
Dulcenombre Gómez-Garre
23Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Hospital Clínico San Carlos
24Laboratorio de Riesgo Cardiovascular y Microbiota, Hospital Clínico San Carlos; Departamento de Fisiología, Facultad de Medicina, Universidad Complutense de Madrid (UCM).
25Biomedical Research Networking Center in Cardiovascular Diseases (CIBERCV), Madrid, Spain
María Teresa Martínez Larrad
23Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Hospital Clínico San Carlos
26Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM)
Emilio Franco-Macías
27Dementia Unit, Department of Neurology, Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBiS), Sevilla, Spain
Pablo Mir
28Unidad de Trastornos del Movimiento, Servicio de Neurología y Neurofisiología. Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Seville, Spain
3CIBERNED, Network Center for Biomedical Research in Neurodegenerative Diseases, National Institute of Health Carlos III, Madrid, Spain
Miguel Medina
29CIEN Foundation/Queen Sofia Foundation Alzheimer Center
3CIBERNED, Network Center for Biomedical Research in Neurodegenerative Diseases, National Institute of Health Carlos III, Madrid, Spain
Raquel Sánchez-Valle
30Alzheimer’s disease and other cognitive disorders unit. Service of Neurology. Hospital Clínic of Barcelona. Institut d’Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain
Oriol Dols- Icardo
31Department of Neurology, Sant Pau Memory Unit, Sant Pau Biomedical Research Institute, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain
María Eugenia Sáez
32CAEBI, Centro Andaluz de Estudios Bioinformáticos, Sevilla, Spain
Ángel Carracedo
5Grupo de Medicina Xenómica, Centro Nacional de Genotipado (CEGEN-PRB3-ISCIII). Universidade de Santiago de Compostela, Santiago de Compostela, Spain
33Fundación Pública Galega de Medicina Xenómica – CIBERER-IDIS, Santiago de Compostela, Spain
Lluís Tárraga
1Ace Alzheimer Center Barcelona – Universitat Internacional de Catalunya, Spain
3CIBERNED, Network Center for Biomedical Research in Neurodegenerative Diseases, National Institute of Health Carlos III, Madrid, Spain
Montse Alegret
1Ace Alzheimer Center Barcelona – Universitat Internacional de Catalunya, Spain
3CIBERNED, Network Center for Biomedical Research in Neurodegenerative Diseases, National Institute of Health Carlos III, Madrid, Spain
Sergi Valero
1Ace Alzheimer Center Barcelona – Universitat Internacional de Catalunya, Spain
3CIBERNED, Network Center for Biomedical Research in Neurodegenerative Diseases, National Institute of Health Carlos III, Madrid, Spain
Marta Marquié
1Ace Alzheimer Center Barcelona – Universitat Internacional de Catalunya, Spain
3CIBERNED, Network Center for Biomedical Research in Neurodegenerative Diseases, National Institute of Health Carlos III, Madrid, Spain
Mercè Boada
1Ace Alzheimer Center Barcelona – Universitat Internacional de Catalunya, Spain
3CIBERNED, Network Center for Biomedical Research in Neurodegenerative Diseases, National Institute of Health Carlos III, Madrid, Spain
Pascual Sánchez Juan
4Neurology Service, Marqués de Valdecilla University Hospital (University of Cantabria and IDIVAL), Santander, Spain
3CIBERNED, Network Center for Biomedical Research in Neurodegenerative Diseases, National Institute of Health Carlos III, Madrid, Spain
Jose Enrique Cavazos
34South Texas Medical Science Training Program, University of Texas Health San Antonio, San Antonio
35Glenn Biggs Institute for Alzheimer’s & Neurodegenerative Diseases, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA
Alfredo Cabrera
36Neuroscience Therapeutic Area, Janssen Research & Development, Turnhoutseweg 30, 2340 Beerse, Belgium
Amanda Cano
1Ace Alzheimer Center Barcelona – Universitat Internacional de Catalunya, Spain
3CIBERNED, Network Center for Biomedical Research in Neurodegenerative Diseases, National Institute of Health Carlos III, Madrid, Spain
Agustín Ruiz
1Ace Alzheimer Center Barcelona – Universitat Internacional de Catalunya, Spain
3CIBERNED, Network Center for Biomedical Research in Neurodegenerative Diseases, National Institute of Health Carlos III, Madrid, Spain
35Glenn Biggs Institute for Alzheimer’s & Neurodegenerative Diseases, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA
Data Availability
The data that support the findings of this study are publicly available from the corresponding authors upon reasonable request. Additionally, the raw SOMAscan proteomic data is publicly accessible through the Alzheimer's Disease Data Initiative (ADDI) community.
Posted September 06, 2024.
Connecting genomic and proteomic signatures of amyloid burden in the brain
Raquel Puerta, Itziar de Rojas, Pablo García-González, Clàudia Olivé, Oscar Sotolongo-Grau, Ainhoa García-Sánchez, Fernando García-Gutiérrez, Laura Montrreal, Juan Pablo Tartari, Ángela Sanabria, Vanesa Pytel, Carmen Lage, Inés Quintela, Nuria Aguilera, Eloy Rodriguez-Rodriguez, Emilio Alarcón-Martín, Adelina Orellana, Pau Pastor, Jordi Pérez-Tur, Gerard Piñol-Ripoll, Adolfo López de Munian, Jose María García-Alberca, Jose Luís Royo, María Jesús Bullido, Victoria Álvarez, Luis Miguel Real, Arturo Corbatón Anchuelo, Dulcenombre Gómez-Garre, María Teresa Martínez Larrad, Emilio Franco-Macías, Pablo Mir, Miguel Medina, Raquel Sánchez-Valle, Oriol Dols- Icardo, María Eugenia Sáez, Ángel Carracedo, Lluís Tárraga, Montse Alegret, Sergi Valero, Marta Marquié, Mercè Boada, Pascual Sánchez Juan, Jose Enrique Cavazos, Alfredo Cabrera, Amanda Cano, Agustín Ruiz, Alzheimer’s Disease Neuroimaging Initiative
medRxiv 2024.09.06.24313124; doi: https://doi.org/10.1101/2024.09.06.24313124
Connecting genomic and proteomic signatures of amyloid burden in the brain
Raquel Puerta, Itziar de Rojas, Pablo García-González, Clàudia Olivé, Oscar Sotolongo-Grau, Ainhoa García-Sánchez, Fernando García-Gutiérrez, Laura Montrreal, Juan Pablo Tartari, Ángela Sanabria, Vanesa Pytel, Carmen Lage, Inés Quintela, Nuria Aguilera, Eloy Rodriguez-Rodriguez, Emilio Alarcón-Martín, Adelina Orellana, Pau Pastor, Jordi Pérez-Tur, Gerard Piñol-Ripoll, Adolfo López de Munian, Jose María García-Alberca, Jose Luís Royo, María Jesús Bullido, Victoria Álvarez, Luis Miguel Real, Arturo Corbatón Anchuelo, Dulcenombre Gómez-Garre, María Teresa Martínez Larrad, Emilio Franco-Macías, Pablo Mir, Miguel Medina, Raquel Sánchez-Valle, Oriol Dols- Icardo, María Eugenia Sáez, Ángel Carracedo, Lluís Tárraga, Montse Alegret, Sergi Valero, Marta Marquié, Mercè Boada, Pascual Sánchez Juan, Jose Enrique Cavazos, Alfredo Cabrera, Amanda Cano, Agustín Ruiz, Alzheimer’s Disease Neuroimaging Initiative
medRxiv 2024.09.06.24313124; doi: https://doi.org/10.1101/2024.09.06.24313124
Subject Area
Subject Areas
- Addiction Medicine (373)
- Allergy and Immunology (690)
- Anesthesia (184)
- Cardiovascular Medicine (2760)
- Dermatology (236)
- Emergency Medicine (414)
- Epidemiology (12413)
- Forensic Medicine (10)
- Gastroenterology (784)
- Genetic and Genomic Medicine (4272)
- Geriatric Medicine (396)
- Health Economics (702)
- Health Informatics (2761)
- Health Policy (1021)
- Hematology (370)
- HIV/AIDS (880)
- Medical Education (404)
- Medical Ethics (112)
- Nephrology (454)
- Neurology (4054)
- Nursing (218)
- Nutrition (600)
- Oncology (2134)
- Ophthalmology (607)
- Orthopedics (251)
- Otolaryngology (313)
- Pain Medicine (256)
- Palliative Medicine (77)
- Pathology (479)
- Pediatrics (1150)
- Primary Care Research (470)
- Public and Global Health (6663)
- Radiology and Imaging (1453)
- Respiratory Medicine (886)
- Rheumatology (422)
- Sports Medicine (353)
- Surgery (465)
- Toxicology (57)
- Transplantation (192)
- Urology (171)